Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Mason currently holds 391,054 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Mason has been a net seller of ALNY stock. They have purchased $0 and sold $12.3M worth of shares.
Michael Mason's most recent insider trade was on Sep 4, 2024, when they sold 7,050 shares at $0.72 per share.
Michael Mason serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 103 insider transactions totaling $12.3M over their tenure at the company.
Michael Mason holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Michael Mason has shown a selling trading pattern, with $0 in total purchases and $12.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Mason was on Jan 4, 2018, when they sold $2.2M worth of ALNY shares. This transaction involved 16,500 shares at $131.20 per share.
Michael Mason currently owns 391,054 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Mason's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Mason has 103 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Michael Mason and 40,000+ other insiders.